Login
  • Home
  • Direct Healthcare Professional Communications

all ( 12 results found)

Sort by:

Date Last Updated:

Medicine Status DHPC Document Name Additional Communications Company Epipen Junior 150 micrograms solution for injection in pre-filled pen
No Recent Update

EpiPen® Healthcare Professional Letter COM

COM 15/08/23
Mylan IRE Healthcare Ltd Epipen 300 micrograms solution for injection in pre-filled pen
No Recent Update

EpiPen® Healthcare Professional Letter COM

COM 15/08/23
Mylan IRE Healthcare Ltd Quinsair 240 mg nebuliser solution
No Recent Update

Fluoroquinolones DHPC_HPRA_FINAL vs2 30-05-23 COM

COM 14/06/23
Chiesi Limited Gavreto 100 mg hard capsules
No Recent Update

Gavreto DHPC dated 16 Jun 2023 COM

COM 19/06/23
Roche Registration GmbH IMBRUVICA 140 mg, 280 mg, 420 mg and 560 mg film-coated tablets
Updated

IMBRUVICA® (ibrutinib): New risk minimisation measures, including dose modification recommendations, due to the increased risk for serious cardiac events COM

COM 04/11/22
Janssen Sciences Ireland Topamax 200mg film-coated tablets
No Recent Update

Topamax: Ongoing EU review of potential risk of neurodevelopmental disorders in children exposed in utero COM

COM 19/10/22
Janssen Sciences Ireland Topamax Sprinkle 25 mg hard capsules
Updated

Topamax: Ongoing EU review of potential risk of neurodevelopmental disorders in children exposed in utero COM

COM 19/10/22
Janssen Sciences Ireland Topamax Sprinkle 15 mg hard capsules
Updated

Topamax: Ongoing EU review of potential risk of neurodevelopmental disorders in children exposed in utero COM

COM 19/10/22
Janssen Sciences Ireland Topamax 50mg film-coated tablets
No Recent Update

Topamax: Ongoing EU review of potential risk of neurodevelopmental disorders in children exposed in utero COM

COM 19/10/22
Janssen Sciences Ireland Topamax 25mg film-coated tablet
No Recent Update

Topamax: Ongoing EU review of potential risk of neurodevelopmental disorders in children exposed in utero COM

COM 19/10/22
Janssen Sciences Ireland Topamax 100mg film-coated tablets
No Recent Update

Topamax: Ongoing EU review of potential risk of neurodevelopmental disorders in children exposed in utero COM

COM 19/10/22
Janssen Sciences Ireland Zolgensma 2 × 1013 vector genomes/mL solution for infusion
No Recent Update

Zolgensma (onasemnogene abeparvovec): Important Safety Information COM

COM 20/02/23
Novartis Ireland Limited